Grief can be isolating, but it rarely happens in isolation. In this two-episode arc, Kelsie talks to friends who have been there before, during and after Chris' ALS diagnosis.

In Part 1, she talks first to Flames Assistant General Manager Craig Conroy, who was hired to the Flames front office the same year as Chris, and next General Manager Brad Treliving, who has been Chris' boss since he was hired as Flames GM in 2014.

Kelsie talks with Craig and Brad about what it's been like to experience this alongside them -- from the early days when they were hoping it was anything but ALS, to the diagnosis and going public, as well as all the hope of the clinical trial seemingly coming to fruition and the heartbreak when everyone realized the trial drug wasn't stopping Chris' ALS entirely. They talk about how Chris' illness has changed their relationships with him, whether they think it has changed Chris and, finally, how it has changed them.

Support the show

Immediately after Chris was diagnosed with ALS at 37 years old and given 6-18 months to live, we learned he could join an exciting clinical trial for a drug that would be the only hope of saving his life or, at the very least, extending it. The one thing dampening our hope was the fact that Chris had a 1-in-3 chance of getting a placebo rather than the medication during the trial. This, along with hiding his illness from most of the world and, in time, figuring out how to tell people about it, coloured our next several months after Chris' diagnosis. 

Support the show

We all have a sad story, and in this episode I will start to tell mine. Here's where I tell you what it's like to be told your 37-year-old husband has 6-18 months to live, and what it's like when an experimental drug gives him a chance to rewrite his diagnosis.

Support the show